Michael A. Young, MHA, FACHE, President and CEO of Temple University Hospital and Temple University Health System, provided perspective to Becker’s Hospital Review on “one question that hospital CEOs need answered right now.”
Michael A. Young, MHA, FACHE, President and CEO of Temple University Hospital and Temple University Health System, provided perspective to Becker’s Hospital Review on “one question that hospital CEOs need answered right now.”
A novel “on-the-table” therapeutic strategy with a total procedure time of less than one hour can safely reduce the size of blood clots lodged in the pulmonary arteries and eliminate the need for post-procedural drug infusion in an intensive care unit, according to Katz School of Medicine research.
Read MoreHealio highlighted the key takeaways from Dr. Criner’s session on how to identify and treat patients with COPD plus diabetes or osteoporosis.
Read More